PF Warriors is excited to invite you to a special Zoom clinical trial presentation. Join us to learn about the REVERT IPF, a phase 2 clinical trial to evaluate the [Read More]
PF Warriors
PF Warrior to Warrior Open Q&A – January 23, 2025
Register now for this monthly online PF Warriors open question and answer meeting. This discussion is led by patients and caregivers. Ask questions and learn more about living with pulmonary fibrosis (PF). [Read More]
PF Warriors Educational Meeting – December 14, 2024
PF Warrior Zoom Meeting: Lung Aging and Predisposition to Pulmonary Fibrosis You are invited to join PF Warriors and Dr. Jesse Roman for an informative session on “Lung Aging and [Read More]
PF Warriors Educational Meeting – January 11, 2025
Portable Oxygen Concentrator (POC): Making the Right Choice for Your Lifestyle Oxygen is essential to all of us—especially when living with pulmonary fibrosis (PF). Portable oxygen concentrators (POCs) can offer freedom [Read More]
PF Warrior to Warrior Open Q&A – November 21, 2024
***Special Meeting Date*** Register now for this monthly online PF Warriors open question and answer meeting. This discussion is led by patients and caregivers. Ask questions and learn more about living with [Read More]
Guerreros de Fibrosis Pulmonar: October 18, 2024
Los hispanohablantes están invitados a asistir a una reunión de un grupo de apoyo internacional para personas con fibrosis pulmonar. Cada mes, la reunión está dirigida por Nancy Lee y [Read More]
PF Warriors Zoom Meeting: Update on the Zinc Protocol and introduction to the Phase I Atezolizumab Study for PF @ Cedars-Sinai Los Angeles – October 12, 2024
PF Warriors is pleased to invite you to an upcoming meeting featuring key updates on pulmonary fibrosis (PF) research. Our distinguished speakers, Dr. Paul Noble and Dr. Tanzira Zaman from [Read More]
Special ILD Day Webinar
Join us for a very special webinar presentation on Wednesday, September 18 at noon central time with Drs. Sonye Danoff and Erin Wilfong. This year, the topic of ILD Day [Read More]
